The Discounted Cash Flow (DCF) valuation of Harmony Biosciences Holdings Inc (HRMY) is (745.85) USD. With the latest stock price at 32.39 USD, the upside of Harmony Biosciences Holdings Inc based on DCF is -2402.7%.
Note: valuation result may not be accurate due to the low predictability of business.
| Range | Selected | |
| WACC / Discount Rate | 5.3% - 9.1% | 7.2% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (7,057.95) - (405.74) | (745.85) |
| Upside | -21890.5% - -1352.7% | -2402.7% |